Dose once or twice daily with precision application¹

OXISTAT^® Lotion is available in 2 bottle sizes: 30 mL and 60 mL.

OXISTAT^® Lotion 30 mL features the convenient interdigital applicator for PRECISION APPLICATION

Helps minimize waste
Precludes the need for patients to touch the affected area during application

OXISTAT® (oxiconazole nitrate) Lotion 30 mL bottle with interdigital applicator

Prescribe OXISTAT^® Lotion by name! To help ensure your patients receive the treatment you prescribed, specify “OXISTAT^® Lotion” and DAW or DNS.*

* Dispense as written (DAW), do not substitute (DNS), or equivalent language in your state.

Reference: 1. OXISTAT^® Cream, OXISTAT^® Lotion [Prescribing Information, 2012]. Melville, NY: PharmaDerm, a division of Fougera Pharmaceuticals Inc.

Important Safety Information

For topical dermatologic use only and not for ophthalmic or intravaginal use.
OXISTAT^® (oxiconazole nitrate) Lotion is contraindicated in individuals who have shown hypersensitivity to any of its components. If a reaction suggesting sensitivity or chemical irritation should occur with the use of OXISTAT^® Lotion, treatment should be discontinued and appropriate therapy instituted. If signs of epidermal irritation should occur, the drug should be discontinued.
In a clinical trial with OXISTAT^® Lotion (N=269), the most common adverse events were burning and stinging (0.7% each) and pruritus, scaling, tingling, pain and dyshidrotic eczema (0.4% each).
Please see Full Prescribing Information for OXISTAT^® Lotion.
You are encouraged to report negative side effects of prescription drugs to the FDA. Please visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indication

OXISTAT^® Lotion is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum.

The information on this site is intended for U.S. residents only.
OXISTAT^® is a registered trademark of Fougera Pharmaceuticals, Inc.
© 2021 ANI Pharmaceuticals, Inc. All rights reserved.

Site Map | Terms of Use | Privacy Policy | ANI Pharmaceuticals, Inc

The information on this site is intended for U.S. residents only.
10470 Rev 06/21

Dose once or twice daily with precision application1

Important Safety Information

Indication

Dose once or twice daily with precision application¹